ACTA1 and diabetes mellitus: The drug was also demonstrated to reduce the expression of von Willebrand factor and α smooth muscle cell actin (αSMA), the well-known markers of endothelial cell transition into fibroblastic phenotype, upregulated by the induction of diabetes.